Integra Issues Recall Of Intracranial Pressure Monitors

Company also adjusts its earnings forecast

Integra LifeSciences has recalled CereLink intracranial pressure monitors because of reports they were providing inaccurate readings. The company adjusted its third quarter earnings expectations in response.

Integra LifeSciences announced a global recall of its CereLink intracranial pressure monitors on 18 August after receiving reports that the devices were producing readings that were out of range.

In a filing with the US Securities and Exchange Commission, the New Jersey-based manufacturer says that it plans to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

MHRA’s Tallon Hails PMS Regulation As Start Of UK Device Framework Transformation

17 Jun 2025

• By Ashley Yeo

16 June marked the first major new regulatory instrument in the UK’s post-Brexit transition to a standalone device regulatory system for Great Britain.

Increasing Safety Concerns Spur Scrutiny of Device Plastics Use

13 Jun 2025

• By Elizabeth Orr

With new regulations limiting the use of plastics popping up worldwide, the medtech industry sees arguments on both sides. Some argue hasty bans of PFAS ("forever chemicals") would harm patients, while others say phthalates should be phased out to protect the public.

With LDT Rule DOA, Could FDA Shift Focus To RUOs?

13 Jun 2025

• By Brian Bossetta

Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?